Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The French pharmaceuticals market registered revenue of $75 billion in 2023, representing a compound annual growth rate (CAGR) of 2.5% between 2018 and 2023.
France captured a 20.3 % share of the European pharmaceuticals market in 2023.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in France
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts
Reasons to Buy
What was the size of the France pharmaceuticals market by value in 2023?
What will be the size of the France pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the France pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up France's pharmaceuticals market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 Company Profiles
8.1. Les Laboratoires Servier SAS
8.2. Sanofi
8.3. Ipsen SA
8.4. Laboratoires Pierre Fabre SA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: France pharmaceuticals market value: $ billion, 2018-23
Table 2: France pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: France pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: Les Laboratoires Servier SAS: Key Facts
Table 5: Les Laboratoires Servier SAS: Key Employees
Table 6: Sanofi: Key Facts
Table 7: Sanofi: Annual Financial Ratios
Table 8: Sanofi: Key Employees
Table 9: Sanofi: Key Employees Continued
Table 10: Ipsen SA: Key Facts
Table 11: Ipsen SA: Annual Financial Ratios
Table 12: Ipsen SA: Key Employees
Table 13: Ipsen SA: Key Employees Continued
Table 14: Laboratoires Pierre Fabre SA: Key Facts
Table 15: Laboratoires Pierre Fabre SA: Key Employees
Table 16: France Size of Population (million), 2019-23
Table 17: France Real GDP (constant 2010 prices, $ billion), 2019-23
Table 18: France GDP (current prices, $ billion), 2019-23
Table 19: France Inflation, 2019-23
Table 20: France Consumer Price Index (absolute), 2019-23
Table 21: France Exchange Rate, 2018-23
List of Figures
Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)